发明名称 FENOFIBRATE-CONTAINING COMPOSITION
摘要 <P>PROBLEM TO BE SOLVED: To maintain bioavailability at a high level by improving elution properties of fenofibrate. <P>SOLUTION: The fenofibrate-containing composition contains fenofibrate (A) and a nonionic fatty acid ester-based surfactant (B). In the nonionic fatty acid ester-based surfactant (B), HLB may be around 1-20. The fenofibrate-containing composition may contain co-pulverized granules of the fenofibrate (A) and the nonionic fatty acid ester-based surfactant (B). The ratio of the nonionic fatty acid ester-based surfactant (B) to 100 pts.wt. of the fenofibrate (A) may be around 1-10 pts.wt. The fenofibrate-containing composition may further contain at least one selected from a binder, an excipient, and a disintegrator. <P>COPYRIGHT: (C)2013,JPO&INPIT
申请公布号 JP2013047282(A) 申请公布日期 2013.03.07
申请号 JP20120265109 申请日期 2012.12.04
申请人 ASKA PHARMACEUTICAL CO LTD 发明人 KANAZAWA HAJIME;OKAMOTO MASARU;TANIMORI NAOTO
分类号 A61K31/216;A61K9/20;A61K9/48;A61K47/14;A61K47/34;A61K47/36;A61P3/06 主分类号 A61K31/216
代理机构 代理人
主权项
地址